VIA·L
‹ Усі статті

Припливи: чому вони бувають і що насправді допомагає

4 хвилини читанняПеревірено спеціалістом VIA-L · 17.10.2026

Жар піднімається до обличчя й шиї, кидає в піт, потім може морозити. Уночі те саме будить, і зранку здається, що ви не спали зовсім. Припливи — одна з найчастіших ознак перименопаузи й менопаузи. Добра новина: про них багато відомо, і частина звичних порад працює, а частина — ні. Розберімося, де що.

Чому тіло раптом перегрівається

У кожного з нас є «зона теплового комфорту» — діапазон, у якому тіло не намагається ні охолонути, ні зігрітися. Коли в перехідні роки знижується естроген, ця зона звужується. Тепер тілу вистачає зовсім невеликого підвищення температури, щоб вирішити, що пора терміново охолоджуватися: судини розширюються, шкіра червоніє, виступає піт.

Зазвичай поруч із припливами йдуть нічна пітливість, уривчастий сон, сухість, ниючі суглоби й «туман» у голові. Це одна картина, а не набір окремих бід. Якщо у вас є кільце чи годинник, уночі на них часто видно різкі стрибки температури шкіри разом із пробудженнями.

Чому вночі найгірше

Більшість нічних припливів збігається з пробудженням. Ніч рветься на шматки, і зранку немає сил, гірший настрій, сильніше тягне на солодке. Тому все, що зменшує нічні пробудження, допомагає не лише з припливами, а й з усім днем.

Що допомагає — за силою доказів

Силові тренування двічі на тиждень. Це найсильніший важіль без ліків. У найкращому дослідженні припливів стало приблизно вдвічі менше, а настрій покращувався, навіть коли сила й вага ще не змінилися. Починати варто саме з цього, а не відкладати «на потім».

Когнітивно-поведінкова терапія і клінічний гіпноз. Це єдині методи без ліків із сильною опорою саме щодо припливів. Після КПТ припливи менше турбують і менше заважають жити, гіпноз знижує і їхню частоту. Бувають групові, онлайн- і книжкові формати; веде психолог чи психотерапевт із такою практикою.

Прохолодна темна спальня. Близько 16–19 °C, тканини, що дихають, одяг і ковдра шарами, щоб уночі легко зняти зайве. Чесно: охолодження не повертає «зону комфорту», але помітно зменшує пробудження й дискомфорт.

Менше алкоголю й кофеїну. Алкоголь посилює припливи навіть у невеликих кількостях і ріже другу половину ночі. Кава й міцний чай — до 14:00.

Що не допомагає від припливів, хоч часто радять

У жодної безрецептурної добавки переконливої опори щодо припливів немає.

Коли варто піти до лікаря

Якщо припливи часто будять уночі або заважають працювати й жити — це привід іти до лікаря, а не терпіти. Найдієвіше тут — рецептурне: є і гормональні, і негормональні варіанти. Це повноцінний варіант, а не «провал природного шляху»; харчування й звички залишаються підтримкою, а не заміною.

І ще одна причина розповісти лікарю про припливи: сильні й тривалі припливи та нічна пітливість — не лише дискомфорт. Лікарі враховують їх, коли оцінюють серце й судини, — а після менопаузи це особливо важливо.

Що спробувати цього тижня

Відмічайте припливи щодня у VIA-L: за два-три тижні буде видно, що з цього працює саме у вас.

На чому ґрунтується

Статтю написано за темами бази знань VIA-L. За ними стоять опубліковані роботи — ось вони:

  1. Cognitive Behavioural Therapeutics for Insomnia Symptoms in the Perimenopause Through to the Early Postmenopausal Period — The Cochrane Database of Systematic Reviews, 2026 doi
  2. Real-World Safety Profile of Fezolinetant: A Disproportionality Analysis Based on the FAERS Database — Naunyn-Schmiedeberg's Archives of Pharmacology, 2026 doi
  3. Integrative Approaches to Perimenopause — The American Journal of Medicine, 2026 doi
  4. Effect of Lactobacillus-Based Probiotics on Genitourinary Syndrome of Menopause in Post-Menopausal Women: A Systematic Review — Maturitas, 2026 doi
  5. Hepatic Adverse Event Signals of Fezolinetant in Real-World Use Based on Postmarketing Surveillance — Obstetrics and Gynecology, 2026 doi
  6. Integrative Medicine Approaches for Menopause — Obstetrics and Gynecology, 2026 doi
  7. Reframing menopause and menopause hormone therapy as opportunities for healthy aging — Science, 2026 doi
  8. Insomnia and women: exploring vulnerability, impact, and intervention — Sleep & Breathing = Schlaf & Atmung, 2026 doi
  9. OSA in Women: Associations With Reproductive Aging and Screening Challenges — Chest, 2026 doi
  10. Pharmacological and Non-Pharmacological Treatments for Chronic Insomnia in Perimenopausal and Postmenopausal Women: A Systematic Review and Meta-Analysis — Sleep Medicine, 2026 doi
  11. FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes — JAMA, 2025 doi
  12. Nonhormonal Treatment of Menopausal Vasomotor Symptoms — JAMA Internal Medicine, 2025 doi
Показати всі (136)
  1. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial — JAMA Internal Medicine, 2025 doi
  2. Self-Administered Hypnosis vs Sham Hypnosis for Hot Flashes — JAMA Network Open, 2025 doi
  3. Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies — Advances in Therapy, 2025 doi
  4. Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms — Drugs, 2025 doi
  5. Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Advances in Nutrition (Bethesda, Md.), 2025 doi
  6. Evidence-Based Guideline: Premature Ovarian Insufficiency — Fertility and Sterility, 2025 doi
  7. The Effectiveness of Mindfulness-Based Interventions on Menopausal Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Journal of Affective Disorders, 2025 doi
  8. The Role of Lifestyle Medicine in Menopausal Health: A Review of Non-Pharmacologic Interventions — Climacteric : The Journal of the International Menopause Society, 2025 doi
  9. European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause — European Journal of Endocrinology, 2025 doi
  10. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis — Obstetrics and Gynecology, 2025 doi
  11. Gut Microbiota Has the Potential to Improve Health of Menopausal Women by Regulating Estrogen — Frontiers in Endocrinology, 2025 doi
  12. Natural Strategies to Optimize Estrogen Levels in Aging Women: Mini Review — Frontiers in Aging, 2025 doi
  13. Effects of Soy Isoflavones on Menopausal Symptoms in Perimenopausal Women: A Systematic Review and Meta-Analysis — PeerJ, 2025 doi
  14. Menopause and Movement: Exercise for Better Sleep and Psychological Well-Being-a Systematic Review — Menopause (New York, N.Y.), 2025 doi
  15. Omega-3 Fatty Acids and Sleep: Recent Advances in Understanding Effects and Mechanisms — Current Opinion in Clinical Nutrition and Metabolic Care, 2025 doi
  16. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms — JAMA Internal Medicine, 2025 doi
  17. Long-Term Hormone Therapy for Perimenopausal and Postmenopausal Women — The Cochrane Database of Systematic Reviews, 2025 doi
  18. Association Between Life's Essential 8 and Cardiovascular, Cancer, and Other Cause Mortality: The REGARDS Study — Advances, 2025 doi
  19. Improving Cardiovascular Clinical Competencies for the Menopausal Transition: A Focus on Cardiometabolic Health in Midlife — Advances, 2025 doi
  20. Impact of Aerobic Exercise on Cardiovascular and Mental Health in Postmenopausal Women: A Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2025 doi
  21. 12-Week Nitrate-Rich Beetroot Extract Supplementation Improves Lower Limb Vascular Function and Serum Angiogenic Potential in Postmenopausal Women — Heart and Circulatory Physiology, 2025 doi
  22. Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association — Circulation, 2025 doi
  23. Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — : 1979), 2025 doi
  24. An Empowerment Model for Managing Menopause — Lancet (London, England), 2024 doi
  25. "Not feeling like myself" in perimenopause - what does it mean? Observations from the Women Living Better survey — Menopause, 2024 doi
  26. Mapping Global Prevalence of Menopausal Symptoms Among Middle-Aged Women: A Systematic Review and Meta-Analysis — BMC Public Health, 2024 doi
  27. Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults — JAMA Psychiatry, 2024 doi
  28. Network Meta-Analysis Examining Efficacy of Components of Cognitive Behavioural Therapy for Insomnia — Clinical Psychology Review, 2024 doi
  29. Effects of Mind-Body Exercise on Perimenopausal and Postmenopausal Women: A Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2024 doi
  30. Stimulus control for insomnia: A systematic review and meta-analysis — J Sleep Res, 2024 doi
  31. Social jetlag and obesity: A systematic review and meta-analysis — Obes Rev, 2024 doi
  32. Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review — Journal of the American College of Cardiology, 2024 doi
  33. Management of Menopausal Symptoms: A Review — JAMA, 2023 doi
  34. Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms — JAMA Network Open, 2023 doi
  35. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review — Archives of Gynecology and Obstetrics, 2023 doi
  36. Fezolinetant: First Approval — Drugs, 2023 doi
  37. EMAS Position Statement: Vitamin D and Menopausal Health — Maturitas, 2023 doi
  38. Resistance Training for Postmenopausal Women: Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2023 doi
  39. A Dietary Intervention for Vasomotor Symptoms of Menopause: A Randomized, Controlled Trial — Menopause (New York, N.Y.), 2023 doi
  40. Black Cohosh Extracts in Women With Menopausal Symptoms: An Updated Pairwise Meta-Analysis — Menopause (New York, N.Y.), 2023 doi
  41. The 2023 Nonhormone Therapy Position Statement of the North American Menopause Society — Menopause (New York, N.Y.), 2023 doi
  42. Rethinking Menopausal Hormone Therapy: For Whom, What, When and How long? — Circulation, 2023 doi
  43. Effect of hysterectomy on ovarian function: a systematic review and meta-analysis — J Ovarian Res, 2023 doi
  44. GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder — CNS Drugs, 2023 doi
  45. The Effect of Caffeine on Subsequent Sleep: A Systematic Review and Meta-Analysis — Sleep Medicine Reviews, 2023 doi
  46. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial — Lancet, 2023 doi
  47. Oral Micronized Progesterone for Perimenopausal Night Sweats and Hot Flushes a Phase III Canada-Wide Randomized Placebo-Controlled 4 month Trial — Scientific Reports, 2023 doi
  48. Optimizing Sleep Across the Menopausal Transition — Climacteric : The Journal of the International Menopause Society, 2023 doi
  49. Relationship between daytime napping with the occurrence and development of diabetes: a systematic review and meta-analysis — BMJ Open, 2023 doi
  50. Effects of Exercise Training on Metabolic Syndrome Risk Factors in Post-Menopausal Women - A Systematic Review and Meta-Analysis of Randomised Controlled Trials — Clinical Nutrition (Edinburgh, Scotland), 2023 doi
  51. Major Global Coronary Artery Calcium Guidelines — Cardiovascular Imaging, 2023 doi
  52. Physical Exercise Effects on Cardiovascular Autonomic Modulation in Postmenopausal Women-a Systematic Review and Meta-Analysis — International Journal of Environmental Research and Public Health, 2023 doi
  53. Efficacy of Cognitive Therapy and Behavior Therapy for Menopausal Symptoms: A Systematic Review and Meta-Analysis — Psychological Medicine, 2022 doi
  54. Effects of Exercise on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis — Climacteric : The Journal of the International Menopause Society, 2022 doi
  55. Results of a Pilot Study of a Cooling Mattress Pad to Reduce Vasomotor Symptoms and Improve Sleep — Menopause (New York, N.Y.), 2022 doi
  56. Resistance Training Reduced Luteinising Hormone Levels in Postmenopausal Women in a Substudy of a Randomised Controlled Clinical Trial: A Clue to How Resistance Training Reduced Vasomotor Symptoms — PloS One, 2022 doi
  57. Systematic review and meta-analyses on the effects of afternoon napping on cognition — Sleep Med Rev, 2022 doi
  58. A Portrait of Obstructive Sleep Apnea Risk Factors in 27,210 Middle-Aged and Older Adults in the Canadian Longitudinal Study on Aging — Scientific Reports, 2022 doi
  59. Disruption of Sleep Continuity During the Perimenopause: Associations With Female Reproductive Hormone Profiles — The Journal of Clinical Endocrinology and Metabolism, 2022 doi
  60. Would you like to explore the evidence for menopausal hormone therapy as a cardiovascular risk modifier, including the "timing hypothesis" and the distinction between early initiation (Menopause: A Cardiometabolic Transition — Diabetes & Endocrinology, 2022 doi
  61. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure Among Patients With Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials — Advances in Nutrition (Bethesda, Md.), 2022 doi
  62. Coenzyme Q10 as Adjunctive Therapy for Cardiovascular Disease and Hypertension: A Systematic Review — The Journal of Nutrition, 2022 doi
  63. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association — Circulation, 2022 doi
  64. The Effect of Vitamin MK-7 on Bone Mineral Density and Microarchitecture in Postmenopausal Women With Osteopenia, a 3-Year Randomized, Placebo-Controlled Clinical Trial — Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021 doi
  65. Cognitive Behavioral Therapy for Menopausal Symptoms — Climacteric : The Journal of the International Menopause Society, 2021 doi
  66. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial — JAMA, 2021 doi
  67. Omega-3 Fatty Acids for Depression in Adults — The Cochrane Database of Systematic Reviews, 2021 doi
  68. Omega-3 Long-Chain Polyunsaturated Fatty Acid and Sleep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Longitudinal Studies — Nutrition Reviews, 2021 doi
  69. Sleep During Menopausal Transition: A 10-Year Follow-Up — Sleep, 2021 doi
  70. Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis — Int J Environ Res Public Health, 2021 doi
  71. Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids: JACC Focus Seminar — Journal of the American College of Cardiology, 2021 doi
  72. Coenzyme Q10 for Patients With Cardiovascular Disease: JACC Focus Seminar — Journal of the American College of Cardiology, 2021 doi
  73. The National Lipid Association Scientific Statement on Coronary Artery Calcium Scoring to Guide Preventive Strategies for ASCVD Risk Reduction — Journal of Clinical Lipidology, 2021 doi
  74. The Effect of Beetroot Inorganic Nitrate Supplementation on Cardiovascular Risk Factors: A Systematic Review and Meta-Regression of Randomized Controlled Trials — Nitric Oxide : Biology and Chemistry, 2021 doi
  75. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study — BMJ, 2021 doi
  76. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association — 2021 doi
  77. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN — Journal of the American Heart Association, 2021 doi
  78. The Effect of Oral Capsule of Curcumin and Vitamin E on the Hot Flashes and Anxiety in Postmenopausal Women: A Triple Blind Randomised Controlled Trial — Complementary Therapies in Medicine, 2020 doi
  79. Altered Activity of Xenobiotic Detoxifying Enzymes at Menopause - A Cross-Sectional Study — Environmental Research, 2020 doi
  80. Calcium, Vitamin D, Vitamin K2, and Magnesium Supplementation and Skeletal Health — Maturitas, 2020 doi
  81. Hormone Therapy for Postmenopausal Women — The New England Journal of Medicine, 2020 doi
  82. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association — Circulation, 2020 doi
  83. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update — Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2020 doi
  84. The Allopregnanolone to Progesterone Ratio Across the Menstrual Cycle and in Menopause — Psychoneuroendocrinology, 2020 doi
  85. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review — Journal of the American College of Cardiology, 2020 doi
  86. HOPE for Rational Statin Allocation for Primary Prevention: A Coronary Artery Calcium Picture Is Worth 1000 Words — Mayo Clinic Proceedings, 2020 doi
  87. Impact of Lifestyles (Diet and Exercise) on Vascular Health: Oxidative Stress and Endothelial Function — Oxidative Medicine and Cellular Longevity, 2020 doi
  88. Dietary and Pharmacological Fatty Acids and Cardiovascular Health — The Journal of Clinical Endocrinology and Metabolism, 2020 doi
  89. Effects of Drugs, Phytoestrogens, Nutrients and Probiotics on Endothelial Dysfunction in the Estrogen-Deficient State — Current Pharmaceutical Design, 2020 doi
  90. Prevention of Endothelial Dysfunction and Cardiovascular Disease by N-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation — Current Pharmaceutical Design, 2020 doi
  91. Soy Intake and Vasomotor Menopausal Symptoms Among Midlife Women: A Pooled Analysis of Five Studies From the InterLACE Consortium — European Journal of Clinical Nutrition, 2019 doi
  92. Pheochromocytoma and Paraganglioma — The New England Journal of Medicine, 2019 doi
  93. Chronotype and Social Jetlag: A (Self-) Critical Review — Biology (Basel), 2019 doi
  94. Use of Risk Assessment Tools To Guide Decision-Making in The Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology — Journal of the American College of Cardiology, 2019 doi
  95. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines — 2019 doi
  96. Aging Women and Their Endothelium: Probing the Relative Role of Estrogen on Vasodilator Function — Heart and Circulatory Physiology, 2019 doi
  97. Effect of Omega-3 Supplements on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis — European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2018 doi
  98. Mindfulness-Based Stress Reduction (MBSR) or Psychoeducation for the Reduction of Menopausal Symptoms: A Randomized, Controlled Clinical Trial — Scientific Reports, 2018 doi
  99. Symptoms of menopause — global prevalence, physiology and implications — Endocrinology, 2018 doi
  100. Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-Reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials — Sleep, 2018 doi
  101. Reprint Of: Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series — Journal of the American College of Cardiology, 2018 doi
  102. The Role of Inorganic Nitrate and Nitrite in Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Human Evidence — Nutrition Reviews, 2018 doi
  103. Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists — Circulation, 2018 doi
  104. Effects of low‐to‐moderate alcohol supplementation on urinary estrogen metabolites in postmenopausal women in a controlled feeding study — Cancer Medicine, 2017 doi
  105. Omega-3 Versus Isoflavones in the Control of Vasomotor Symptoms in Postmenopausal Women — Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 2017 doi
  106. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis — JAMA, 2016 doi
  107. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis — JAMA Cardiol, 2016 doi
  108. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol — The New England Journal of Medicine, 2016 doi
  109. Dietary Nitrate, Nitric Oxide, and Cardiovascular Health — Critical Reviews in Food Science and Nutrition, 2016 doi
  110. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association — Circulation, 2016 doi
  111. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials — : 1979), 2016 doi
  112. Duration of menopausal vasomotor symptoms over the menopause transition — JAMA Intern Med, 2015 doi
  113. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms — Obstetrics and Gynecology, 2015 doi
  114. Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion — Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine, 2015 doi
  115. Exercise for vasomotor menopausal symptoms — Cochrane Database of Systematic Reviews, 2014 doi
  116. Efficacy of Omega-3 for Vasomotor Symptoms Treatment: A Randomized Controlled Trial — Menopause (New York, N.Y.), 2014 doi
  117. Co-Enzyme Q10 Supplementation for the Primary Prevention of Cardiovascular Disease — The Cochrane Database of Systematic Reviews, 2014 doi
  118. Fruit, Mediterranean-Style, and High-Fat and -Sugar Diets Are Associated With the Risk of Night Sweats and Hot Flushes in Midlife: Results From a Prospective Cohort Study — The American Journal of Clinical Nutrition, 2013 doi
  119. Perceived Control, Lifestyle, Health, Socio-Demographic Factors and Menopause: Impact on Hot Flashes and Night Sweats — Maturitas, 2011 doi
  120. Pathophysiology and Treatment of Menopausal Hot Flashes — Seminars in Reproductive Medicine, 2005 doi
  121. Integrating Complementary Medicine Into Cardiovascular Medicine — Journal of the American College of Cardiology, 2005 doi
  122. Is This Woman Perimenopausal? — JAMA, 2003 doi
  123. Diagnostic Role of Follicle-Stimulating Hormone (FSH) Measurements During the Menopausal Transition--an Analysis of FSH, Oestradiol and Inhibin — European Journal of Endocrinology, 1994 doi
  124. The Association Between Moderate Alcoholic Beverage Consumption and Serum Estradiol and Testosterone Levels in Normal Postmenopausal Women: Relationship to the Literature — Alcoholism, Clinical and Experimental Research, 1992 doi

Доказова сила цих робіт різна: десь великі огляди та мета-аналізи, десь окремі невеликі дослідження. Кроки в статті — прості заходи турботи про себе з низьким ризиком, а не лікування, і підходять не всім.

Це загальні відомості, а не призначення. Дозу й схему лікування підбирає лікар.

Застосунок VIA-L

VIA-L — застосунок для жінок від 35 і чоловіків від 40 років: сон, енергія, настрій і тіло в період гормональних змін. Простими словами, за вашими даними — і з перевіркою, що допомогло.

Усі статті бібліотеки є й у застосунку.

Читати далі